Using oral anticoagulants in breastfeeding women

2 November 2021Thromboembolic disease management whilst breastfeeding is challenging. Warfarin is the preferred choice. Guidance on using DOACs is also provided.

Advising on missed or delayed doses of medicines

15 October 2021Guidance to advise people who occasionally forget or are late in taking a dose of their medicine(s).

Oral anticoagulant formulations suggested for adults with swallowing difficulties

1 July 2021A range of oral anticoagulants are suitable for adults with swallowing difficulties.

Using COVID-19 vaccines in patients with anticoagulation and bleeding disorders

7 January 2021Information on use of the vaccine in patients who are receiving anticoagulants or have a bleeding disorder is given below.

Consultations (counselling) about oral anticoagulants apixaban, dabigatran, edoxaban, rivaroxaban and warfarin for patients with aphasia

8 October 2020These resources are designed to support all clinicians who communicate with patients prescribed warfarin  or direct oral anticoagulants (DOACs), formerly known as novel  oral anticoagulants…
Search Articles

Medicine Compliance Aid Stability

MarevanAmdipharm Mercury Co Ltd

Amdipharm Mercury Co Ltd
Tablets 500 micrograms, 1mg, 3mg, 5mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Protect from light
Protect from moisture
Hygroscopic. Store in airtight containers. Protect from light as it is discolored by light.
9 November 2015

Lactation Safety Information

Vitamin K antagonist
Limited published evidence of safety
Extensive experience of safe use in breastfeeding
Only negligible amounts in breast milk
No adverse effects reported in breastfed infants
1 November 2021